Intervacc has applied for supplementary protection certificates for Strangvac in key European markets
Stockholm, February 1, 2022 - The European patent for Strangvac, a vaccine against equine strangles, is approved and in force until May 2031. Pending the approval of the supplementary protection certificates, the protection in Great Britain, Sweden, the Netherlands, Italy, Ireland, France, Spain, Germany and Austria will be extended until May 2036.
Supplementary protection certificates (SPCs) are an intellectual property right that serves as an extension of the monopoly conferred by a patent, however limited to the specific pharmaceutical and plant protection product authorised by
Elkem has today secured 100% ownership of the Elkem Salten energy recovery plant, after acquiring the remaining 50% stake from Kvitebjørn Energi. The transaction is attractive to Elkem and provides increased strategic flexibility.On 15 November, Prime Minister Jonas Gahr Støre opened the new energy recovery plant at Elkem Salten in the northern part of Norway. The energy recovery plant is closely integrated with the silicon production process at Elkem Salten, utilizing the excess heat from the silicon furnaces to produce electrical power. The plant recovers 28% of the electrical energy used
